|2014 was another good year for NNIT. Net turnover increased by 9.3 percent. Operating profit increased by 7.7 percent, corresponding to an operating profit margin of 11.0 percent. The results have been achieved through organic growth and exceed our strategic targets of at least 5 percent net turnover growth and 10 percent operating profit margin.|
|License||Creative Commons Attribution (?)|
Related / Contacts
Related / News
Press releases • Mar 18, 2014 07:00 CET
NNIT's stable organic growth continued in 2013. Turnover increased by 9% to just over DKK 2.2 billion and the pre-tax result for primary operations was DKK 246 million, an increase of 14 % compared to the previous year. In addition, in the past year, NNIT increased its workforce and strengthened its market position via more global sourcing.
Press releases • Jan 15, 2014 08:00 CET
NNIT informs that the company has been requested by Novo Nordisk to explore the potential for a listing on NASDAQ OMX Copenhagen. The aim is to explore the potential for an IPO and to evaluate whether a listing of NNIT would support the continued development and value creation of the company. A decision about the future ownership of NNIT will be made based on the outcome of the evaluation.
Press releases • Mar 13, 2013 07:00 CET
Turnover target for 2014 achieved two years early. 2012 brought continued progress for NNIT. Turnover increased by 13 % to just under DKK 2 billion, which was, in fact, the target for 2014. The pre-tax result for primary operations was DKK 217 million – a 12 % increase on the previous year.
NNIT first six month of 2015: NNIT delivers organic revenue growth of 8.8% and an operating profit margin of 10.7% in constant currencies.
News • Aug 21, 2015 08:46 CEST
NNIT has just published the financial report for the first six months of 2015. Per Kogut, CEO, says: “A solid organic revenue growth of 8.8% and an operating profit margin of 10.7% in constant currencies in the first six months of 2015 is very satisfying. Revenue growth is driven by a 15.9% increase from our non-Novo Nordisk customers in line with our strategy.”
NNIT delivers organic revenue growth of 7.9%, an operating profit margin of 10.3% and free cash flow growth of 38% in 2015.
News • Jan 27, 2016 08:41 CET
NNIT A/S: 1/2016 Financial report for 2015 and Annual General Meeting 2016
Related / Documents
2013 financial performance and 2014 outlook. 2013 was a positive year for NNIT, with a solid growth in revenue and operating profit. Despite challenging market conditions, NNIT managed to grow revenue by 9% and reach an order backlog of DKK 1,803 million for 2014, up by 10% compared to 2013.